301 related articles for article (PubMed ID: 416483)
1. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
Andrade SG; Figueira RM
Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
[No Abstract] [Full Text] [Related]
2. [Treatment of Chagas' disease].
Apt W
Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
[No Abstract] [Full Text] [Related]
3. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
Andrade SG; Silva RC; Santiago CM; Freitas LA
Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
[TBL] [Abstract][Full Text] [Related]
7. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities.
Boechat N; Carvalho AS; Fernandez-Ferreira E; Soares RO; Souza AS; Gibaldi D; Bozza M; Pinto AC
Cytobios; 2001; 105(409):83-90. PubMed ID: 11393774
[TBL] [Abstract][Full Text] [Related]
8. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
[TBL] [Abstract][Full Text] [Related]
9. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
[No Abstract] [Full Text] [Related]
10. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
[TBL] [Abstract][Full Text] [Related]
11. [The therapeutic effect of allopurinol on American trypanosomiasis (Chagas disease) in CFW mice].
Castrillón Rivera LE; García Fernández W; Pérez Gutiérrez C
Salud Publica Mex; 1984; 26(2):146-54. PubMed ID: 6427943
[No Abstract] [Full Text] [Related]
12. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
[TBL] [Abstract][Full Text] [Related]
13. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC
Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection.
dos Santos DM; Talvani A; Guedes PM; Machado-Coelho GL; de Lana M; Bahia MT
Exp Parasitol; 2009 Jan; 121(1):8-14. PubMed ID: 18848935
[TBL] [Abstract][Full Text] [Related]
16. [Genetic diversity and Trypanosoma cruzi clone resistance to treatment with benzonidazole].
de Ornelas Toledo MJ; de Lana M
Rev Soc Bras Med Trop; 2006; 39 Suppl 3():70-2. PubMed ID: 17605212
[No Abstract] [Full Text] [Related]
17. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice.
Malanga CM; Conroy J; Cuckler AC
J Parasitol; 1981 Feb; 67(1):35-40. PubMed ID: 6785408
[No Abstract] [Full Text] [Related]
19. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
[TBL] [Abstract][Full Text] [Related]
20. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
